Sera Prognostics (SERA) Asset Utilization Ratio (2021 - 2026)
Sera Prognostics (SERA) posted Asset Utilization Ratio of 0.0 for Q1 2026, down 24.38% on a QoQ basis from 0.0 in Q4 2025, and down 51.63% year-over-year from 0.0 in Q1 2025.
Sera Prognostics (SERA) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Sera Prognostics' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.0 for Q1 2026.
- Quarterly Asset Utilization Ratio fell 51.63% year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (down 51.63% YoY) and the FY2025 annual result came in at 0.0, up 1.28% from the prior year.
- Asset Utilization Ratio was 0.0 for Q1 2026 at Sera Prognostics, down from 0.0 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.0 in Q2 2023 and bottomed at 0.0 in Q1 2026.
- A 5-year average of 0.0 and a median of 0.0 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 322.02% — and 2024, when it sank 69.21%.
- Sera Prognostics' Asset Utilization Ratio stood at 0.0 in 2022, then soared by 43.35% to 0.0 in 2023, then sank by 69.21% to 0.0 in 2024, then declined by 24.09% to 0.0 in 2025, then declined by 24.38% to 0.0 in 2026.
- Business Quant data shows SERA's Asset Utilization Ratio at 0.0 in Q1 2026, 0.0 in Q4 2025, and 0.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | 0.74 |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | 0.57 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 0.65 |
| 10 | Sera Prognostics | 107.05 Mn | 107.05 Mn | -28,000.00 | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |